Heather Patterson PGY-1 - PowerPoint PPT Presentation

1 / 73
About This Presentation
Title:

Heather Patterson PGY-1

Description:

Thought Disorders and Dissociative States Heather Patterson PGY-1 January 26, 2006 Outline Approach to psychosis in ED Safety Chemical Restraints Assessment and ... – PowerPoint PPT presentation

Number of Views:134
Avg rating:3.0/5.0
Slides: 74
Provided by: Heat45
Category:

less

Transcript and Presenter's Notes

Title: Heather Patterson PGY-1


1
Thought Disorders and Dissociative States
  • Heather Patterson PGY-1
  • January 26, 2006

2
Outline
  • Approach to psychosis in ED
  • Safety
  • Chemical Restraints
  • Assessment and Medical Screening
  • Thought form Disorders
  • Medication side effects
  • Dissociative Disorders

3
Psych history
  • Identifying Data
  • Complaint and HPI
  • Psych Functional Inquiry
  • Mood
  • Anxiety
  • Psychosis
  • Suicide
  • Drugs/EtOH
  • Past Psych Hx
  • Past Med Hx
  • Social Hx
  • Family Hx
  • Is the patient reliable? Do you need a
    collaborative source?

4
Mental Status Exam
  • A appearance
  • S speech
  • E emotion (mood affect)
  • P perception
  • T thought process content
  • I insight / judgment
  • C cognition

5
Mental Status Exam
  • Thought Process
  • Circumstantiality, tangential, flight of ideas,
    loosening of associations, thought blocking,
    neologisms, clanging, perseveration, word salad,
    echoalia
  • Thought Content
  • Obsessions, delusions, ideation, thought
    insertion/withdrawl/broadcasting
  • Perceptual Disturbance
  • Hallucinations, illusion, depersonalization,
    derealization

6
Case
  • 18 year old man living with adopted parents who
    are in late 60s and early 70s.
  • Brought in by police after lighting himself on
    fire.
  • Police brought photos of his room feces stained
    sheets, urine stored in jars in closet, death,
    Satan, blood written on his wall with blood in
    large letters.
  • Angry that he is in the ED, in a waiting area
    for psyc patients, pacing.

7
What do you want to do first?
8
ED Psych Assessment
  • 1. How safe am I with this patient? Are they in
    the right environment?

2. Is patient acutely agitated/psychotic and in
need of prompt treatment?
3. Is patients condition due to an underlying
toxic or medical cause?
4. What is the diagnosis?
9
1. Safety First
  • Assume nothing!
  • Quiet area
  • Patient changed into gown
  • Maintain awareness of your enviro ie sharp
    objects and potential hazards
  • Position yourself near door /- security
  • Do not touch the patient!
  • Be calm

10
ED Psych Assessment
  • 1. How safe am I with this patient? Are they in
    the right environment?

2. Is patient acutely agitated/psychotic and in
need of prompt treatment?
3. Is patients condition due to an underlying
toxic or medical cause?
4. What is the diagnosis?
11
Psychosis
Mental and behavioural disorder causing gross
distortion or disorganization of - mental
capacity - affective response -
capacity to recognize reality -
communication - ability to relate to others.
12
Case (cont)
  • Your patient, now in a gown, is enraged that he
    is balls naked and demands to be let go.
  • He doesnt want to see a doctor. He knows all
    about us and what we are trying to do. He was
    warned not to trust us.
  • He continues to talk about the conspiracy. He is
    pacing in the psych room, his gown flying behind
    him in the breeze.

13
Chemical restraints
  • Review of the literature from 1990-2003 looking
    at different treatment regimes for management of
    acute agitation and psychosis
  • - classic antipsychotics vs benzos vs both
  • - atypical antipsychotis vs classic
    antipsychotics /- benzos
  • Patients with final diagnosis of psychiatric
    disorder in ED and inpatient wards.

Yildiz et al 2003. Pharmacological management of
agitation in the ED. Emerg Med J 200320339-346
Re
14
typical vs. benzos vs. combo
  • 11 trials, 701 subjects (inpatients and ED)
  • Results measured by several previously validated
    assessment scales
  • 7 trials compared typical vs benzos
  • 4 typical more efficacious than benzos
  • 3 benzos better for antiagitation
  • 2 with insignificant differences
  • 4 trials compared typical vs combo.
  • All showed significantly better results with
    combo
  • Decreased EPS with combo

Yildiz et al 2003. Pharmacological management of
agitation in the ED. Emerg Med J 200320339-346
Re
15
typical vs. benzos vs. combo
Conclusion Haloperidol 5mg IV lorazepam 2 mg
PO/IV is effective for rapid tranquilization of
agitated patients in ED
Yildiz et al 2003. Pharmacological management of
agitation in the ED. Emerg Med J 200320339-346
Re
16
atypical vs. benzos vs. combo
  • 5 trials, 3 used blind design.
  • 711 subjects
  • Atypicals were significantly more efficacious
    than the active comparator in 3 studies and
    equally efficacious as the active comparator in 2
    studies.
  • Side effects
  • 3 studies report significantly less EPS than
    typical antipsychotics

Yildiz et al 2003. Pharmacological management of
agitation in the ED. Emerg Med J 200320339-346
17
atypical vs. benzos vs. combo
Conclusion Atypical antipsychotics in moderate
doses are an effective alternative for treatment
of agitation in the ED.
Yildiz et al 2003. Pharmacological management of
agitation in the ED. Emerg Med J 200320339-346
18
Chemical Restraints
  • European multicentre open label, controlled trial
  • 226 patients
  • Chose either po or standard im therapy
  • Evaluated patient at 2 hours using 2 prev
    validated tools.
  • Observed for 24 hours

Lejeune et al Oral risperidone plus oral
lozazepam vs standard care with im conventional
neuroleptics in the initial phase of treating
individuals with acute psychosis. Int Clin
Psychopharmacol 2004 19259-269
19
  • Results
  • Oral resperidone 2mg 2-2.5 mg lorazepam PO was
    significantly non-inferior to standard IM
    therapy /- benzo.
  • Ie no significant difference between groups!
  • Trend to have higher success in atypical drug
    group
  • EPS significantly lower in the atypical drug
    group.
  • Other side effects of drugs were not
    significantly different

Lejeune et al Oral risperidone plus oral
lozazepam vs standard care with im conventional
neuroleptics in the initial phase of treating
individuals with acute psychosis. Int Clin
Psychopharmacol 2004 19259-269
20
What does the American Association for Emergency
Psychiatry say?
Oral preps preferred to IM because less invasive
and increase compliance with long term
treatment. Building evidence that atypical
antipsychotics have some advantage treating
positive, negative, and cognitive features of
schizophrenia.
21
ED Psych Assessment
  • 1. How safe am I with this patient? Are they in
    the right environment?

2. Is patient acutely agitated/psychotic and in
need of prompt treatment?
3. Is patients condition due to an underlying
toxic or medical cause?
4. What is the diagnosis?
22
DDx Acute Psychosis
3. Cause of psychosis
  • Psychiatric d/o
  • Metabolic d/o
  • Inflammatory d/o
  • Vitamin deficiencies
  • Neurologic d/o
  • Endocrine d/o
  • Organ Failure
  • Uremia, hep.enceph

23
  • Pharmacological Agents
  • Anxiolytics
  • Antibiotics
  • Anticonvulsants
  • Antidepressants
  • Cardiovascular drugs
  • Drugs of Abuse
  • Antihistamines
  • Steriods
  • Antineoplastics
  • Cimetidine
  • Heavy metals

24
vs
M Memory A Activity D Distortions F
Feelings O Orientation C Cognition S Some
other findings!
25
MADFOCS
MEMORY
Recent Impairment
Remote impairment
26
MADFOCS
ACTIVITY
Psychomotor retardation Tremor Ataxia
Repetitive activity Rocking Posturing
27
MADFOCS
DISTORTIONS
Auditory Hallucinations
Visual Hallucinations
28
MADFOCS
FEELINGS
Emotional Lability
Flat Affect
29
MADFOCS
ORIENTATION
Oriented
Disoriented
30
MADFOCS
COGNITION
Islands of Lucidity Perceives occasionally Attends
occasionally Focuses
Continuous scattered thoughts Unfiltered
perceptions Unable to attend
31
MADFOCS
SOME OTHER FINDINGS!
Age gt40 Sudden onset Physical exam
abnormal Vitals abnormal Social
immodesty Aphasia Consciousness impaired
Agelt40 Gradual onset Physical exam normal Vitals
normal Social modesty Intelligible speech Awake
and alert
32
Medical Screening
  • Retrospective, observational analysis of psych
    patients in academic urban ED over 2 month period
  • 352 pts with psych chief complaints, 65 (19) had
    a medical problem of any type.

Olshaker et al Medical clearance and screening of
psychiatric patients in the emergency department.
Acad Emerg Med 1997 4(2)124-8
33
Test Sensitivity
Hx 94
Exam 51
Vitals 17
Labs 20
Self reportg (EtOH, drug) 92
  • Concluded that universal lab and tox screening is
    low yield in patients with psych complaints.

34
Medical clearance
Medical Screening
  • Retrospective chart review for 5 months
  • - Included all patients gt16 yo who required a
    psych evaluation before discharge/admission
  • 212 patients, 80 with isolated psych complaint
    with a documented past psych history
  • All patients had CBC, lytes, BUN, Cr, Urine, Tox
    screen, bHCG, CXR

Korn et al 2000 Medical clearance of
psychiatric patients without medical complaints
in the emergency department. J Emerg Med 2000
18(2)173-6
35
  • Results
  • None of the 80 patients with psych complaints
    only had positive screening lab or xray results
  • Conclusion
  • Patients with a primary psych complaint,
    documented past hx, stable vitals and normal exam
    do not need screening medical tests.

Korn et al 2000 Medical clearance of
psychiatric patients without medical complaints
in the emergency department. J Emerg Med 2000
18(2)173-6
36
Consensus statement from The Massachusetts
College of Emergency Physicians Suggest psych
patients with low medical risk do not require
medical screening tests. Low risk patients
include 1. Age between 15 55 2. No acute
medical complaints 3. No new psych
features 4. No evidence of a pattern of
substance abuse 5. Normal physical exam
including vitals.
37
Tips from Dr. S. Finch, Queens Emerg Psych
If you think that this is an acute decompensation
of a chronic psychiatric disease, ensure - No
medical complaints - Vitals and exam are
normal - Previous decompensations follow the
same pattern (may need old charts/family
members/friends for information
38
Case (cont)
On history our patient admitted that he didnt
feel like taking his antipsychotics. He decided
to stop about 1 week ago. He reported only
psych complaints. He had a well documented
history of schizophrenia with similar episodes of
decompensation with non-adherence to treatment
regimes. (although lighting himself on fire was
a new one.)
39
Physical examination was not performed.
Screening labs and tox screen were
negative. Disposition Patient was admitted to
the Psychiatry Unit at Hotel Dieu Hospital for
3-4 weeks Seen on Princess Street 4.5 weeks
later. Appeared well groomed. No charred
clothing!
40
ED Psych Assessment
  • 1. How safe am I with this patient? Are they in
    the right environment?

2. Is patient acutely agitated/psychotic and in
need of prompt treatment?
3. Is patients condition obviously due to an
underlying toxic or medical cause?
4. What is the diagnosis?
41
Schizophrenia
  • EPIDEMIOLOGY
  • Prevalence 0.5-1 of population
  • MF
  • Mean age of onset
  • Females 27
  • Males - 21

42
Schizophrenia
ETIOLOGY- MULTIFACTORIAL
  • Genetic
  • Family history
  • Twin studies
  • Age of father
  • Ante/perinatal exposures
  • Relationship to structural abnormalities?
  • Geographical variance
  • Winter season of birth

43
Schizophrenia dx criteria
  • 2 for 1 month
  • Delusions
  • Hallucinations
  • Disorganized speech
  • Disorganized or catatonic behaviour
  • Negative symptoms
  • B. Sharp deterioration of prior level of function
  • C. Signs of disturbance for 6 months
  • D. Schizoaffective and mood disorders ruled out
  • E. Not caused by medical problem or substance
    abuse.

44
Schizophrenia
  • PREMORBID PHASE
  • Negative symptoms predominate
  • Deterioration from previous level of social,
    personal, and intellectual functioning
  • Typically withdraw from social interactions and
    personal care deteriorates.
  • Difficulty functioning at work/school and
    eventually at home.

45
Schizophrenia
  • ACTIVE PHASE
  • Development of positive symptoms
  • Delusions, hallucinations, bizarre behaviour
  • Agitation or hypervigilant withdrawl state with
    staring or rocking
  • Most likely to see patients in the ED during this
    phase

46
Schizophrenia
  • Residual Phase
  • Resembles premorbid phase
  • Impaired social and cognitive function
  • Bizzare ideation and vague delusions
  • Poor personal hygiene
  • Social Isolation

47
Schizophrenia
  • Treatment
  • antipsychotics
  • psychotherapy
  • Community treatment - social skills training and
    employment programs
  • Prognosis
  • Rules of 1/3s!

48
Brief Psychotic Disorder
  • Diagnosis
  • Acute psychosis lasting 1 day 1 month
  • 1 positive symptom
  • Treatment
  • Antipsychotics, anxiolytics, secure enviro
  • Prognosis
  • Self limiting
  • Should return to premorbid function in 1 month.

49
Schizophreniform disorder
  • Diagnosis
  • Criteria for dx schizophrenia
  • Duration 1-6 months
  • Treatment
  • Antipsychotics, anxiolytics, secure environment
  • Similar to schizophrenia
  • Prognosis
  • Begins and ends abruptly
  • Good post morbid function

50
Schizoaffective disorder
  • Diagnosis
  • Major depressive episode, manic or mixed episode
    concurrent with meeting criteria A for
    schizophrenia
  • Delusions or hallucinations for 2 weeks without
    prominent mood symptoms.
  • Symptoms meeting mood episode criteria present
    for substantial duration of entire active and
    residual pds
  • Treatment
  • Antipsychotics, antidepressants, mood stabilizers
  • Prognosis
  • Not as bad as schizophrenia, not as good as mood
    disorder!

51
Culture bound psychotic syndromes
  • Empacho - Mexico and Cuban America
  • Inability to digest and excrete recently ingested
    food
  • Grisi siknis - Nicaragua
  • Headache, anxiety, anger, aimless running
  • Koro - Asia
  • Fear that penis will withdraw into abdomen
    causing death

52
Delusional disorder
  • Diagnosis
  • Non bizarre delusion 1 month
  • Do not meet criteria A for schiz
  • If mood symptoms with delusions, must be brief
    compared to total delusion time
  • Treatment
  • Antipsychotics, antidepressants, psychotherapy
  • Prognosis
  • Chronic, unremitting
  • High level of functioning

53
Typical Antipsychotics
  • Mechanism of Action
  • Central blockade of DA receptors in limbic
    system, cortex, and basal ganglia
  • Have some anticholinergic, antihistaminergic, and
    adrenergic effects

54
Atypical Antipsychotics
  • Mechanism of Action
  • Block 5HT and DA receptors
  • Some anticholinergic, antihistaminergic, and
    antiadrenergic effects

55
Side Effects eps
  • Acute Dystonic Reaction
  • Incidence 1-5 of patients
  • Pathophys Caused by an imbalance in the
    dopaminergic-cholinergic balance of the basal
    ganglia
  • Onset Within hours to days of meds
  • Clinical Muscle spasms often of eyes, tongue,
    jaw, neck and rarely laryngospasm
  • Rx Benzotropine 1-2m IM
  • Benadryl 50 mg IM

56
Side Effects eps cont.
SIDE EFFECTS (CONT)
  • Parkinsonism
  • Onset weeks after starting medication
  • Risk Elderly at higher risk
  • Clinical Akinesia, Rigidity, Tremor
  • Rx oral anti-parkinsonism drugs but may resolve
    spontaneously over time

57
Side Effects eps cont.
SIDE EFFECTS (CONT)
  • Akathisia
  • Onset after 1 dose or after dose increase
  • Clinical Motor restlessness ie Pacing, fidgety
    leg movements if sitting.
  • Careful not to confuse with agitation
  • Rx Benzotropine 1 mg bid-qid
  • Propranolol 30-60 mg/day

58
Side Effects eps cont.
SIDE EFFECTS (CONT)
  • Tardive Dyskinesia
  • Incidence
  • 0.4-56 with mean of 20
  • related to duration of therapy, cumulative
    dosage, underlying brain injury, and age
  • Risk factors
  • Most common in elderly women and patients with
    assoc mood disorders

59
  • Tardive Dyskinesia (cont)
  • Onset
  • months to years after meds started
  • Clinical
  • Abnormal involuntary movements from mild to
    disfiguring
  • Rx often untreatable
  • Clozapine may be tried
  • Lower doses of antipsychotics with benzos

60
Side Effects eps cont.
Neuroleptic Malignant Syndrome
  • Incidence
  • 0.5-1 of patients
  • Mechanism
  • - DA depletion in CNS with defective
    thermoregulation in HT
  • Risk factors
  • - long acting depot antipsyc meds, exhaustion,
    dehydration.
  • Onset
  • - weeks after initiating treatment OR after
    increase of meds OR treatment with high doses in
    ED

61
Neuroleptic Malignant Syndrome (Cont)
Clinical -High fever, rigidity, altered LOC,
autonomic instability, ?CK - May also see
Resp failure GI bleed Hepatic and renal
failure Cardiovascular collapse
Coagulopathy Treatment - Dantrolene 1mg/kg IV
push - Repeat to max 10mg/kg
62
Side Effects Non EPS
SIDE EFFECTS (CONT)
  • Sedation
  • Pathophys Mediated via histamine receptors
  • Postural Hypotension
  • Pathophys Mediated by alpha-1 receptors.
  • Risk Particularly problematic in elderly.
  • Rx trandelenburg, fluids, 02. Dopamine should
    only be used for severe unresponsive episodes.
    Pressors with B-agonist activity are
    contraindicated.
  • May necessitate switch to another medication

63
Side Effects Non EPS (cont)
SIDE EFFECTS (CONT)
  • Dry Mouth, Blurred Vision, Constipation, Urinary
    Retention
  • Pathophys Mediated by Cholinergic receptor
    blockade
  • May necessitate change in meds
  • Hyperprolactinemia
  • - Pathophys DA blockade
  • - May see gynecomastia, impotence, amenorrhea

64
Side Effects Non EPS (cont)
SIDE EFFECTS (CONT)
Weight Gain - Mechanism unknown - Seen commonly
with atypical antipsychotics Agranulocytosis -
Seen with use of Clozapine. - Not likely to be
seen b/c patients have regular screening.
65
Dissociative Disorders
  • Dissociation split between conscious awareness
    and disturbing memories or feelings.
  • Can affect both memory and behaviour
  • Disorders evolve when patients continue to use
    these defenses even when they are no longer
    needed.
  • Not conscious fabrications

66
Dissociative Fugue
  • Abrupt onset of memory loss about identity and
    life experiences
  • Occurs after traumatic emotional conflict or
    experience
  • Patients tend to wander far from home and assume
    a new identity

67
Dissociative identity disorder
  • Patient has 2 or more distinct personality states
  • May not be completely aware of alternate
    identities
  • memory lapses may signal a switch

may also lose acquired skill during the switch
but regain once new personality takes
over. Evident gaps in memory childhood
location
68
Who do we evaluate?
Patients who have difficulty remembering their
past or who seem confused about their identity.
69
Dissociative symptoms screening questions
  1. Has the patient noticed episodes of lost time?
  2. Has the patient found themselves somewhere with
    no idea how they got there?
  3. Has the patient been recognized by people who are
    strangers to them?
  4. Has the patient discovered personal possessions
    in their home that does not remember acquiring?

St. Frances Guide to Psychiatry
70
Tips from Dr. S. Finch, Queens Emerg Psych
  • Be careful not to assume someone is faking it.
  • Careful physical exam if possible
  • Often no history is available
  • Ativan 1-2 mg SL/IV
  • 45min the patient may have loosened up enough
    to talk to you
  • Dissociation often is a result of trauma.
    Hospitals can re-traumatize patients. Be aware
    of this and minimize potentially traumatic
    situations.

71
ddx for dissociative disorders
  1. Head trauma
  2. Epilepsy
  3. Vascular Disease with TIAs
  4. Encephalopathy
  5. Dementia
  6. Delerium
  7. Schizophrenia
  8. Substance Abuse

72
Approach to dissociative disorders
  1. Careful History if possible - Benzos if needed
  2. Careful Physical Exam
  3. ? Screening medical tests to assist with
    differential diagnosis
  4. Consult Psychiatry!

73
Summary
  • Approach to psychosis in ED
  • Safety
  • Chemical Restraints
  • Assessment and Medical Screening
  • Thought form Disorders
  • Medication side effects
  • Dissociative Disorders
Write a Comment
User Comments (0)
About PowerShow.com